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ABSTRACT
The prevalence, pathogenic indices, such as haemolytic and haemagglutinating activities, antibiograms, 
and in-vitro activities of local medicinal plants against Aeromonas isolates in Vhembe district of Limpopo 
province, South Africa, were studied using standard microbiological methods. In total, 309 diarrhoeic stool 
samples were collected from patients attending five health centres in the region during December 2004–
May 2005. Aeromonas species were identified using the API 20E system. The haemagglutinating and hae-
molytic activities of isolates on human, sheep, pig and chicken red blood cells were investigated. Antibiotic 
susceptibility profiles of the isolates to several antibiotics and in-vitro activity of local medicinal plants were 
also ascertained using previously-reported schemes. Results showed that 104 (33.6%) of the 309 samples 
were positive for Aeromonas species, of which 89 (85.6%) were Aeromonas hydrophila, 12 (11.5%) A. sobria, 
and three (2.9%) A. caviae. All strains of A. hydrophila and A. caviae produced haemolysis on sheep blood, 
while eight of the 12 A. sobria strains were haemolytic on sheep blood. The haemolytic activities of the 
isolates were variable on other red blood cells tested. High level of resistance was observed to amoxicillin 
and ampicillin, followed by cefuroxime (79%), chloramphenicol (74%), and erythromycin (65%). The 
carbapenems were the most active drugs with only 7% resistance to meropenem and 11% to imipenem. 
About 12% of the isolates were resistant to ciprofloxacin. The extracts of three of seven medicinal plants 
tested showed inhibitory activity against all Aeromonas isolates; these included acetone and hexane extracts 
of Pterocarpus angolensis, Syzygium cordatum, and Zornia milneana. The results suggest a high prevalence of 
Aeromonas species in the region. The isolates demonstrated multiple resistant profiles to different antibio-
tics tested. Some local medicinal plants were inhibitory to Aeromonas isolates, indicating a potential role 
in the management of Aeromonas-related infections. Structural elucidation of the active components may 
pave the way for the discovery of candidate templates for eventual drug design. Most isolates possessed 
important virulence characteristics based on their haemolytic and haemagglutinating ability. However, the 
genetic characterization of the isolates will further confirm their pathogenicity and the origin of multiple 
antibiotic resistance. 
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INTRODUCTION
Aeromonas spp. are pathogenic in fish and several 
cold-blooded animals (1,2).  Over the last few years, 
interest in Aeromonas spp. has gone beyond the 
boundaries of fish pathology due to the surge of 
diseases in humans caused by it. Seven Aeromonas 
spp., currently recognized as human pathogens, 
include Aeromonas hydrophila, A. caviae, A. veronii 
biovar sobria, A. veronii biovar veronii, A. jandaei, 
A. trota, and A. schubertii. Other species, such as 
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DISEASE RESEARCH, BANGLADESHA. eucrenophila, were incriminated as a cause of 
fluid accumulation in the rabbit ileal loop test after 
serial passages, indicating a pathogenic potential 
(3). It has also been demonstrated that at least one 
strain of A. trota produces aerolysin (4). Although 
Aeromonas species are opportunistic pathogens for 
humans, studies have shown that they may also 
act as primary pathogens for humans in a number 
of infections (4). 
Aeromonas spp. are distributed worldwide and have 
been implicated in various infections, including di-
arrhoea and extraintestinal infections, such as sep-
ticaemia, wound infections, burn-associated sepsis, 
and respiratory tract infections (5-7). Aeromonads 
were implicated in cases of gastrointestinal infec-
tions in children and in wound infections (8-12). 
Although incriminated in several disease states, the 
mechanisms of pathogenicity of aeromonads are 
not clearly understood, and several virulence fac-
tors have been proposed. These include the produc-
tion of endotoxins, extracellular enterotoxins, hae-
molysins, haemagglutinins, cytotoxins, proteases, 
and siderosphores and the ability to adhere to cells 
and possession of certain surface proteins (13,14). 
Studies have revealed the close association between 
the expression of a cell-free haemolysin by aeromo-
nads and enterotoxigenic activity (13-15). Various 
studies also indicated that enterotoxigenic strains 
of Aeromonas strongly produce haemagglutinins 
(16,17). Therefore, haemolysis and haemaggluti-
nating activities could be strong indicators of en-
terotoxigenicity by Aeromonas species in humans.  
Although infections due to Aeromonas may be self-
limiting, treatment with antibiotics is generally 
necessary to curb the progression and persistence of 
the disease, particularly in vulnerable groups, such 
as the young, elderly, and immunocompromised 
individuals. The growing antibiotic resistance of 
pathogenic bacteria worldwide is a compounding 
factor for the effective management of bacterial 
infections. An increase in antibiotic resistance of 
the genus Aeromonas, particularly to antibiotics, 
has been reported (1,17-19). Attempts have been 
made to elucidate the occurrence and persistence 
of antibiotic resistance among isolates but this was 
mainly on aquatic species (20,21). Relatively, low 
attention has been accorded to the study of antibio- 
tic resistance among human isolates of Aeromonads, 
particularly in Africa. The need for the periodic moni-
toring of   occurrence of   Aeromonas-associated   infections 
and their susceptibility to commonly-used antibio- 
tics is urgent for effective healthcare delivery. The 
present study evaluated the prevalence, pathogenic 
indices, antibiotic susceptibility profiles, and in-vi-
tro activity of medicinal plants against Aeromonas 
isolates from diarrhoeic stool samples of patients 
attending five major health centres in Vhembe dis-
trict, Limpopo province, South Africa.
MATERIALS AND METHODS
Study site and patients 
The study was carried out in Vhembe district in 
the Venda region, Limpopo province of South Af-
rica during December 2004–May 2005. Diarrhoeic 
stool samples were collected from patients attend-
ing the Donald Frazier, Elim, Tshilidzini, Siloam 
and Makhado hospitals. 
Isolation and identification of Aeromonas spp. 
from stool samples
In total, 309 stool samples were collected and in-
vestigated for Aeromonas spp. Microscopic exami-
nation was done with methylene blue stain for 
faecal leucocytes, red blood cells, and mucus. The 
specimens were cultured using the method as pre-
viously described (14). Briefly, freshly-collected 
stool specimens were plated onto MacConkey agar 
and xylose deoxycholate citrate agar (XDCA). Fae-
ces were enrinched in peptone water (pH 8.6) over-
night at 37 ºC. Cultures were incubated at 37 ºC for 
18-24 hours, after which non-lactose-fermenting 
colonies on MacConkey agar and non-xylose-fer-
menting colonies on XDCA were screened for the 
production of oxidase. Oxidase-positive colonies 
were subcultured onto nutrient agar plates. All 
oxidase-positive colonies were further confirmed 
as Aeromonas using the API 20E system (Analytab 
Product). Aeromonas isolates were identified to spe-
cies level using the following tests: esculin hydroly-
sis, Voges-Proskauer, lysine decarboxylase, growth 
in potassium cyanide broth, oxidation of gluconate 
to 2-keto-gluconate, gas production from glucose 
and glycerol, acid production from cellobiose, 
mannose, and lactose, and cell-free activity against 
rabbit erythrocytes (Tables 1 and 2).
Determination of haemolytic activity
The previously-described methods were employed 
for haemolytic activity using sheep, human, horse, 
pig and chicken blood agar. A single colony of each 
isolate was streaked across blood agar plates using 
sterile inoculating wire loop. Plates were incubated 
at 37 ºC for 18-24 hours. After incubation, the hae-
molytic  activities  were  determined  by  observing 
haemolysis on blood agar.
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Determination of haemagglutination activity 
The method of Atkinson and Trust was used 
for the detection of haemagglutinin (15). Erythro-
cytes were collected from human, horse, pig, and 
chicken  into  a  bottle  containing  5%  EDTA  and 
stored at 4 ºC. Before use, they were washed three 
times in a 0.04-M phosphate-buffered saline (PBS) 
with ph 7.4, and a 3% suspension was prepared in 
PBS. Colonies of overnight cultures of Aeromonas 
on nutrient agar plates were incubated in Mueller-
Hinton broth (Oxoid Ltd., London, England) for 18 
hours at 37 ºC. These cultures were centrifuged and 
washed twice in PBS. Haemagglutination tests were 
performed at room temperature by mixing 20 µL 
of erythrocyte suspension with 20 µL of bacterial 
suspension on a slide alongside a control suspen-
sion of erythrocytes and PBS and gently rocking 
by hand. Strains were considered haemagglutina-
tion-positive if agglutination occurred within five 
minutes and negative if agglutination was absent 
within this period.
Testing of antibiotic susceptibility 
Antibiotic susceptibility of the isolates was deter-
mined using the disc-agar diffusion technique (12). 
Several antibiotics were tested and were obtained 
from Oxoid; these included: ciprofloxacin (5 µg), 
erythromycin (30 µg), tetracycline (30 µg), merope-
nem (10 µg), imipenem (10 µg), chloramphenicol 
(10 µg), amoxacillin/clavulanic acid (30 µg), gen-
tamicin (10 µg), amikacin (10 µg), cefoxitin (30 
µg), nalidixic acid (30 µg), piperacillin/tazobactam 
(110 µg), doxycycline (30 µg), co-trimoxazole (25 
µg), cefotaxime (30 µg), cephazolin (30 µg), cefu-
roxime (30 µg), cefepime (30 µg), and ceftrizone 
(30 µg). Briefly, five pure colonies of each bacterial 
strain were inoculated into 2 mL of sterile Mueller-
Hinton broth in bijou bottles and incubated at 37 
ºC for six hours. The turbidity was adjusted to 
match a 0.5 McFarland turbidity standard. A sterile 
cotton-tipped swab was dipped into the standard-
ized bacterial suspension, and the swab was rotated 
against the wall of the tube above the liquid level 
to remove excess inoculum. The inoculum was 
swabbed on the entire surface of a Mueller-Hinton 
agar plate. The automatic disc dispenser, adjusted 
to dispense six antibiotic discs, was applied on the 
surface of the agar, and the plates were incubated at 
37 °C for 24 hours. 
Preparation of plants extracts and essential oils
The following medicinal plants were collected 
from the Venda region. Bauhinia galpinii (family Fa-
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Table 2. Scheme for identification of Aeromonas based on fermentation of acid from arabinose, 
cellobiose, lactose, and inositol
Organism L-Arabinose  Cellobiose Lactose Inositol
A. hydrophila  + - - -
A. sobria    - - - -
A. caviae  + + + -
baceae), Carissa edulis (family Apocynaceae), Ficus 
sycomorus (family Moraceae), Mormodica balsamina 
(family Cucurbitaceae), Syzygium cordatum (family 
Myrtaceae).  Pterocarpus  angolensis  (family  Fabace-
ae), Ximenia caffra (family Olacaceae), and Zornia 
milneana (family Papilionaceae). A 50-g sample 
of each ground material was soaked in 500 mL of 
methanol, acetone, or hexane for at least 72 hours 
with frequent shakings. The samples were suction-
filtered through Whatman No. 1 filter paper. The 
filtrate was evaporated to dryness under reduced 
pressure, collected in 10 mL of the solvent, placed 
in the tube and allowed to dry at room tempera-
ture. A stock solution of 0.2 g/mL in dimethyl sul-
phoxide (DMSO) was made for each extract.  Es-
sential oils were prepared by hydrodistillation for 
three hours using a Cleveland-type apparatus. All 
the extracts and essential oils were kept at 4 oC in 
the dark until further use as described (22).
Antimicrobial assay of plant extracts
The disc-diffusion method was used as described by 
Nostro et al. (22). Briefly, Mueller-Hinton agar was 
supplemented with 0.01% tween 80 to enhance the 
solubilization of oils and extract. 100 µL of 18-hour 
old culture of each test organism was spread on the 
agar plate and left for 30 minutes to dry. Whatman 
paper was used for preparing discs of 6-mm diam-
eter and sterilized by autoclaving. The blank sterile 
discs were deposited on top of the seeded Mueller-
Hinton agar and 15 µL (3 mg) of each extract or 
essential oil was added on top of the disc. The plate 
was incubated at 37 oC for 24 hours. All tests were 
performed in triplicates using 10 µL of 50 mg/mL 
gentamycin as a positive control and 15 µL (6%) of 
DMSO as a negative control. Each test was repeated 
four times, and the antibacterial activity was ex-
pressed as the mean of inhibition diameters (mm) 
produced by the plant extracts (23).
Determination of minimum inhibitory 
concentration
Serial dilutions of the extracts and essential oils 
were made in microtitre wells with Mueller-Hinton 
broth (0.01% tween 80) to cover the range of 0.08 
mg/mL to 12 mg/mL for a volume of 100 µL with 
a final concentration of 2.5% DMSO (Merck, Ger-
many). A McFarland no. 1 standard suspension of 
test bacteria was made in Mueller–Hinton broth, 
from which 100 µL of the final inoculum contain-
ing  approximately  1.5x106  colony-forming  units 
(CFUs) was used for filling each well to a final vol-
ume of 200 µL. Inoculated plates were incubated 
at 37 °C for 24 hours. One hour before the end of 
incubation, 40 µL of a 0.2% solution of iodo-nitro 
tetrazolium (INT) (Merck, Germany) was added to 
the wells, and the plate was incubated for another 
hour.  Inhibition of growth was detected when the 
solution in the well was clear after incubation with 
INT. The assay was repeated three times. The lowest 
concentration of each extract showing no visible 
growth was recorded as the minimum inhibitory 
concentration (MIC).
Statistical analysis
The proportion difference was determined by the 
chi-square test. A p value of <0.05 was considered 
statistically significant. 
RESULTS
Isolation rate of Aeromonas 
In total, 104 (33.66%) Aeromonas spp. were isolated 
from 309 samples screened. A breakdown of results 
showed that 89 (85.6%), 12 (11.5%), and three 
(2.9%) were A. hydrophilia, A. sobria, and A. caviae 
respectively. A. hydrophilia was the most frequently-
isolated species, and the difference was  significant 
(p<0.05). The isolation rates of Aeromonas species 
were higher among male than among female pa-
tients (p<0.05). A. hydrophila was most commonly 
isolated from the age-group of 11-15 years and 31-
40 years in females. No Aeromonas spp. was isolated 
in the age-group of 6-10 years and above 51 years 
in males (Fig. 1). 
Haemagglutinating and haemolytic activity 
Haemagglutination activity of the Aeromonas 
strains tested showed 49% of activity against hu-
man red blood cells (HRBCs), 41% against sheep 
red blood cells (SRBCs), 26% against pig red blood 
cells (PRBCs), and 12% against chicken red blood Obi CL et al. In-vitro activity of medicinal plants against Aeromonas
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cells (CRBCs) (Table 3). A. hydrophila demonstrat-
ed beta-haemolytic activity on all the red blood 
cells tested;  96%, 100%, 58%, and 85% to HRBCs, 
SRBCs, CRBCs, and PRBCs respectively; while A. sob- 
ria showed no haemolytic activity on HRBCs and 
SRBCs. All the A. caviae isolates showed beta-hae-
molysis on HRBCs and SRBCs (Table 4). 
Antimicrobial susceptibility 
Results obtained showed a high incidence of resis-
tance of the isolates to several antibiotics (Fig. 2). 
Resistance to cephalosporins was variable: 34% to 
cefotaxime, 79% to cefuroxime, and 26% to ce-
fepime. Resistance to meropenem (7%), imipenem 
(11%), and ciprofloxacin (12%) was less observed.
Medicinal plants
The results relating to the plant extracts are reported 
in Figure 3. Of eight extracts of eight different plants 
Fig. 1. Age and sex distribution of Aeromonas species isolated in Vhembe district, South Africa
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Table 4:  Haemolytic activities of Aeromonas species on human, sheep, chicken, and pig red 
blood cells
Red blood cells
A. hydrophila (n=89) A. sobria (n=12) A. caviae (n=3)
Positive Positive Positive
No. % No. % No. %
HRBC 85   96 0 - 3 100
SRBC 89 100 0 - 3 100
CRBC 52   58 1 8 0 -
PRBC 76   85 2 17 2   67
CRBC=Chicken red blood cell; HRBC=Human red blood cell; PRBC=Pig red blood cell; 
SRBC=Sheep red blood cell
Table 3.  Haemagglutination activities of 
Aeromonas spp. against human, sheep, 
pig, and chicken red blood cells
Red blood cells 
Isolates showing haemagglu-
tining activity
No.                      %
HRBC 43                       49
SRBC 36                       41
PRBC 23                       26
CRBC 11                       12
CRBC=Chicken red blood cell; HRBC=Human 
red blood cell; PRBC=Pig red blood cell; 
SRBC=Sheep red blood cellObi CL et al. In-vitro activity of medicinal plants against Aeromonas
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obtained, four exhibited activity against Aeromonas 
spp. isolates. Extracts of four plants showed little 
activity against the isolates with MIC of three mg/
mL. The extracts of P. angolensis, S. cordatum, and Z. 
milneana using acetone and hexane as the extract-
ant showed a significant inhibitory effect against 
all the strains of Aeromonas spp. tested.
DISCUSSION
It has been reported that there is a great variabili-
ty in the isolation and distribution of Aeromonas 
species from clinical samples, particularly from 
stool specimens (3). According to Maluping et al., 
Aeromonas spp. were responsible for more dysen-
Fig. 2. Antibiotic susceptibility of Aeromonas spp. isolated from diarrhoeic stools of patients
           attending different health centres in Vhembe district, Limpopo, South Africa 
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Fig. 3. Inhibitory activity of acetone and methanol extracts of different plants against Aeromonas  isolates
>6   3 1.5 0.75 0.37 0.18 0.09 0.04 0.02
MICs in mg/mL
%
 
o
f
 
a
c
t
i
v
i
t
y
MoA
CaA
BaA
PtM
FiA
SyM
SaM
ZmA
0
10
20
30
40
50
60
70
CaA=Carissa edulis using acetone as an extractant; BaA=Bauhinia galpinii using acetone as an extractant; 
FiA=Ficus  sycomorus  using  acetone  as  an   extractant;  MICs=Minimum   inhibitory   concentrations; 
MoA=Mormodica balsamina using acetone as an extractant; PtM=Pterocarpus angolensis using methanol as 
an  extractant;  SaM=Ximenia  caffra  using  methanol  as  an  extractant;  SyM=Syzygium  cordatum  using 
methanol as an extractant; ZmA=Zornia milneana using acetone as an extractant. Key:  Bauhinia galpinii 
(family Fabaceae), Carissa edulis (family Apocynaceae), Ficus sycomorus (family Moraceae), Mormodica 
Balsamina (family Cucurbitaceae), Syzygium cordatum (family Myrtaceae). Pterocarpus angolensis (family 
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tery than Shigella species (24). Studies elsewhere 
revealed that 12.3% of 210 patients screened har-
boured Aeromonas spp. in their faeces (18). In the 
present study, 33% of the diarrheic stool samples 
examined were positive for Aeromonas spp. Al-
though results of some studies showed that Aeromo-
nas spp. were more prevalent in children aged less 
than five years, the present study recorded a higher 
occurrence in adults aged 21-50 years. The higher 
prevalence (33%) underlines the need to include 
Aeromonas spp. in the list of routinely-analyzed 
enteropathogens in all diarrhoeal stool samples as 
previously suggested (14). Our results showing the 
incrimination of A. hydrophila, A. sobria, and A. ca-
viae in diarrhoeic cases are consistent with results of 
previous reports (1,2,7,17) and justify further stud-
ies, such as determination of pathogenic indices 
and antimicrobial activities.
In the present study, A. caviae and A. hydrophilia 
showed high haemolytic activity on human and 
sheep red blood cells. Several authors have shown 
that production of haemolysin is mainly associated 
with strains belonging to the phenospecies—A. hy-
drophila and A. sobria (13,14,17). However, in con-
trast to these reports, A. sobria isolates in this study 
showed no haemolytic effect on either sheep or 
human red cells. This indicates a variation in hae-
molytic activities of Aeromonas species and could 
be linked to the sources of the Aeromonas isolates. 
The present study investigated Aeromonas spp. in 
clinical samples, while previous authors studied 
environmental isolates, such as from water and 
food. These variations may indicate the need for 
detailed studies on the pathogenicity and relation-
ships between environmental and clinical isolates 
of Aeromonas spp. 
Haemolytic activity is an index of pathogenicity, 
and the relationship between the production of 
haemolysin and the enterotoxigenicity in Aeromo-
nas is well-documented (14,15,17). The reported 
haemolytic activities of the isolates in the present 
study point to the potential pathogenic signifi-
cance, although haemolytic activities varied with 
species.
Erythrocytes from small laboratory animals are 
more sensitive than human, horse, or sheep eryth-
rocytes in Aeromonas haemoylsin and haemaggluti-
nins assay (16). However, if the haemoylsin assay is 
to be used routinely in clinical laboratories to detect 
enteropathogenic aeromonads, small animals are 
not practical sources of erythrocytes because of dif-
ficulty in obtaining blood from these animals. The 
result of this study has demonstrated that human, 
horse, or sheep red blood cells may be ade- 
quate for haemolysin and haemagglutination as-
say of Aeromonas. This finding is in harmony with 
reports of other investigators (13,17). Although pig 
and chicken erythrocytes had not been previously 
reported to detect haemolytic and haemagglutinin 
activities of Aeromonas spp., they offer promise in 
the detection of haemagglutinating and haemo-
lytic activities of Aeromonas species, as exemplified 
by results of this study. 
Other major pathogenic features, such as cytotoxic 
enterotoxin (Act) and Type111 secretion system, 
had been described for Aeromonas (25) but were not 
investigated in the present study. A major observa-
tion of the present study was the demonstration 
of multiple antibiotic resistance among Aeromonas 
isolates. This poses a major public-health concern 
and calls for concerted efforts to unravel alterna-
tive sources of treatment. Medicinal plants offer 
such promise. Results have revealed the strong in-
vitro activity of P. angolensis, S. cordatum, and Z. mil-
neana against Aeromonas isolates. Medicinal plants 
are useful sources of drugs (26,27), and the major-
ity of individuals in developing countries rely on 
their uses. Medicinal plants offer cheaper and more 
natural remedies to infections. Structural elucida-
tion of the active components of the plants may be 
a prelude to the discovery of candidate drug tem-
plates for eventual drug designs and development.
It is concluded that diarrhoeagenic Aeromonas spe-
cies were commonly encountered in the region 
studied and could be the cause of diarrhoea in both 
children and adults. Although species of Aeromonas 
studied showed haemagglutinating and haemo-
lytic activities, these may not be conclusive of their 
pathogenicity. Other major pathogenic factors, 
such as heat-labile cytotoxin, heat-stable cytotoxin 
that have enterotoxic activities, will be the subject 
of another investigation.
In the empiric management of Aeromonas-related 
infections, ciprofloxacin, meropenem, and imipe-
nem may be effective as demonstrated by results 
on antibiograms. Further studies are needed to 
fully confirm the strong antimicrobial activity ob-
served for P. angolensis, S. cordatum, and Z. milneana 
against Aeromonas isolates.
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